Allurion Technologies, Inc. (ALUR)
(Delayed Data from NYSE)
$0.68 USD
+0.04 (6.64%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $0.68 0.00 (-0.37%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.68 USD
+0.04 (6.64%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $0.68 0.00 (-0.37%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Zacks News
Allurion (ALUR) Unveils Positive Data for Its Balloon Therapy
by Zacks Equity Research
Allurion (ALUR) announces positive weight loss data for its gastric balloon technology.
Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Allurion Technologies, Inc. (ALUR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.